Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,115.0
-11.1 (-0.35%)

 

  • STI Straits Times Index
    3,115.0
    -11.1 (-0.35%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,599.2
    -1.1 (-0.07%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,734.2
    238.8 (0.94%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,823.8
    8.0 (0.29%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    20,418.8
    13.2 (0.06%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,286.7
    29.1 (0.46%)
    Index delayed 10 minutes
  • KOR KOSPI
    1,927.2
    -11.2 (-0.58%)
    Index delayed 20 minutes
  • XAO XAO
    6,485.9
    -4.9 (-0.08%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 881.1M
  • Value: 1,121.3M
  • Rise: 154
  • Fall: 151
  • Unch: 532

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
YZJ Shipbldg SGD0.990+0.130
LionGold0.001-
ThaiBev0.885-0.020
KLW0.004-
ISR Capital^0.003-
Mapletree NAC Tr1.330+0.040
SingTel3.210-0.020
Seroja Inv^0.078+0.046
Genting Sing0.875+0.005
Synagie0.162+0.010

World Indices

World Indices
Name Last Change
Nasdaq 7,896.0 +129.4
HSI 25,734.2 +238.8
HSCEI 9,964.3 +60.9
Jakarta 6,286.7 +29.1
Nikkei 225 20,418.8 +13.2
SSE Comp 2,823.8 +8.0
Shanghai A 2,958.2 +8.4
Shanghai B 260.6 +1.7
PSE Comp 0.0
KOSPI 1,927.2 -11.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

WEIGAO GROUP WEIGAO GROUP
Quotes 15 Minutes Delayed. Updated at 16 Aug 2019 16:08
Last (HKD): 6.860 Change: +0.080 High: 6.970 Remarks: -
Change (%): +1.18 Low: 6.740
Open 6.780 Yesterday's Close 6.780
Buy Price 6.860 Sell Price 6.870
Buy Volume ('000) 352 Sell Volume ('000) 92
Cumulative Volume ('000) 7,068 Cumulative Value 48,501,160
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.38578 Trailing EPS (HKD) e 0.38578 NAV (HKD) b 3.6600
PE a 17.782 Trailing PE f 17.782 Price / NAV b 1.8743
Dividend (HKD) d 0.114000 Cash In Hand (HKD) g 1.0174 Issued & Paid-up Shares c 4,522,330,000
Dividend Yield (%) d 1.662 Price / Cash In Hand g 6.743 Treasury Shares h -
Beta - 75 Daysi 1.104 R-Squared - 75 Days(%)i 28.11 Market Cap (M) 31,023.184
Beta - 500 Daysi 0.769 R-Squared - 500 Days (%)i 11.69 Enterprise Value (M) 33,208.751
Piotroski F Score 4 Exchange Code 1066 Par Value ( CNY ) 0.10000
52 Weeks Volatility (%) 33.74 6-Month VWAP 7.304 Free Float (%) 50.7
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 09 Aug 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 17 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference WEIGAO GROUP HKEx 31,023.184 17.782 17.782 1.8743 1.662
Industry Medical Specialties HKEx 4,015.517 30.136 30.196 1.6758 1.084
Local Peer MICROPORT HKEx 9,881.920 52.726 52.726 2.8504 0.470
Local Peer CIRC HKEx 6,058.429 15.838 15.838 1.5309 1.630
Local Peer LIFETECH SCI HKEx 5,735.040 39.988 39.989 4.0549 -
Local Peer AK MEDICAL HKEx 5,104.524 29.734 29.735 5.3175 0.713
Local Peer YESTAR HEALTH HKEx 3,358.451 11.263 10.608 2.4982 -
Local Peer GOLDEN MEDITECH HKEx 2,479.390 - - 0.5659 -
Local Peer PW MEDTECH HKEx 1,632.020 12.001 12.001 0.3184 -
Local Peer MODERN DENTAL HKEx 1,043.546 12.220 12.221 0.5228 3.126
Local Peer YUNNAN ENERGY HKEx 809.785 - - 2.7057 -
Local Peer KELFRED HKEx 490.000 16.108 16.108 5.0620 -
Local Peer VINCENT MED HKEx 395.343 12.776 12.776 1.0559 2.581
Local Peer LIFE HEALTHCARE HKEx 160.628 - - 0.4854 -
Other Local Peers HUAKANG BIOMED (HKEx), CH DEMETER FIN (HKEx), MY MEDICARE (HKEx), COMBEST HOLD (HKEx)
Global Peer ABBOTT LABORATORIES NYSE 149,840.172 63.681 52.100 4.7289 1.359
Global Peer MEDTRONIC PLC NYSE 137,817.602 29.760 29.760 2.7513 1.946
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 110,591.447 37.642 31.232 3.8495 0.265
Global Peer DANAHER CORP NYSE 100,682.599 37.981 41.155 3.2901 0.446
Global Peer STRYKER CORP NYSE 80,963.785 22.787 22.807 6.7792 0.892
Global Peer BECTON DICKINSON & CO NYSE 67,037.677 421.620 85.507 3.1188 1.208
Global Peer BOSTON SCIENTIFIC CORP NYSE 58,713.685 35.137 42.059 6.2296 -
Global Peer INTUITIVE SURGICAL INC NASDAQ 57,102.099 50.627 47.200 7.8596 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 45,615.920 63.163 62.927 13.0320 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,403.055 27.342 28.068 5.6839 0.843
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), RESMED INC (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), WATERS CORP (NYSE), HOLOGIC INC (NASDAQ), STERIS PLC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), NOVOCURE LTD (NASDAQ), PERKINELMER INC (NYSE), INSULET CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), COCHLEAR LTD (ASX), MASIMO CORPORATION (NASDAQ), QIAGEN NV (NYSE), HAEMONETICS CORP (NYSE), HILL-ROM HOLDINGS INC (NYSE), BRUKER CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), HARTA (Bursa), LIVANOVA PLC (NASDAQ), CANTEL MEDICAL CORP (NYSE), NEOGEN CORP (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), ICU MEDICAL INC (NASDAQ), NUVASIVE INC (NASDAQ), Top Glove (SGX), TOPGLOV (Bursa), WRIGHT MEDICAL GROUP NV (NASDAQ), CONMED CORP (NASDAQ), QUIDEL CORP (NASDAQ), NEVRO CORP (NYSE), EBOS GROUP (ASX), GLAUKOS CORPORATION (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), AVANOS MEDICAL INC (NYSE), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), STAAR SURGICAL CO (NASDAQ), BIOTELEMETRY INC (NASDAQ), ATRION CORP (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ATRICURE INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), CAREDX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CRYOLIFE INC (NYSE), NANOSONICS LIMITED (ASX), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), INOGEN INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CORINDUS VASCULAR ROBOTICS INC (NYSE American), CERUS CORP (NASDAQ), QUOTIENT LTD (NASDAQ), VERICEL CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), AXOGEN INC (NASDAQ), SURMODICS INC (NASDAQ), HESKA CORP (NASDAQ), ANTARES PHARMA INC (NASDAQ), SI BONE INC (NASDAQ), SUPERMX (Bursa), CORMEDIX INC (NYSE American), ORTHOPEDIATRICS CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), VIEWRAY INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), BIOLIFE SOLUTIONS INC (NASDAQ), AVEDRO INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ZYNEX INC (NASDAQ), SIENTRA INC (NASDAQ), VAPOTHERM INC (NYSE), ENLIVEX THERAPEUTICS LTD (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), ACCURAY INCORPORATED (NASDAQ), IRADIMED CORP (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), CRH MEDICAL CORP (NYSE American), RTI SURGICAL HOLDINGS INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), SEASPINE HOLDINGS CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MISONIX INC (NASDAQ), NEURONETICS INC (NASDAQ), SOLITON INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), FONAR CORP (NASDAQ), INTRICOM CORP (NASDAQ), INVACARE CORP (NYSE), CYTOSORBENTS CORP (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CONFORMIS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ENDOLOGIX INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), SOMNOMED LIMITED (ASX), STRATA SKIN SCIENCES INC (NASDAQ), COMPUMEDICS (ASX), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), NEUROTROPE INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), ONCOCYTE CORP (NYSE American), CYCLOPHARM LIMITED (ASX), SDI LTD (ASX), ELLEX MEDICAL LASERS LTD (ASX), ALPHA PRO TECH (NYSE American), NEPHROS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), ZOSANO PHARMA CORP (NASDAQ), MRI INTERVENTIONS INC (NYSE American), ELECTROCORE INC (NASDAQ), IMPEDIMED LIMITED (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), ELECTROMED INC (NYSE American), IMMUCELL CORP (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), OVENTUS MEDICAL LTD (ASX), Biolidics (SGX), CELSION CORPORATION (NASDAQ), IRIDEX CORP (NASDAQ), RESPIRI LTD (ASX), DAXOR CORP (NYSE American), PAVMED INC (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), MICRO-X LTD (ASX), RESONANCE HEALTH LTD (ASX), BIOMERICA INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), NUVECTRA CORPORATION (NASDAQ), RESTORATION ROBOTICS INC (NASDAQ), BIOLASE INC (NASDAQ), UG Healthcare (SGX), RETRACTABLE TECHNOLOGIES INC (NYSE American), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), REWALK ROBOTICS LTD (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), NEOVASC INC (NASDAQ), ATOSSA GENETICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), ADVENTA (Bursa), Yunnan Energy (SGX), OBJ LIMITED (ASX), MILESTONE SCIENTIFIC INC (NYSE American), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), INSPIREMD INC (NYSE American), CHECK-CAP LTD (NASDAQ), LBT INNOVATIONS LTD (ASX), LIANLUO SMART LIMITED (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), CYANOTECH CORP (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), OPTISCAN IMAGING (ASX), Annica (SGX), Medtecs Intl (SGX), IMAGION BIOSYSTEMS LIMITED (ASX), CARDIEX LTD (ASX), DYNATRONICS CORP (NASDAQ), AVINGER INC (NASDAQ), DIMERIX LTD (ASX), ANALYTICA (ASX), USCOM LTD (ASX), LKL (Bursa), DIGIRAD CORP (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CESCA THERAPEUTICS INC (NASDAQ), MICRON SOLUTIONS INC (NYSE American), CHF SOLUTIONS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), AETHLON MEDICAL (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), STHAI (SET), SINTX TECHNOLOGIES INC (NASDAQ), NEUROMETRIX INC (NASDAQ), METALICITY LIMITED (ASX), ADHERIUM LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGARD LIMITED (ASX), ADMEDUS LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.010
-0.15 %
10 Days --0.340
-4.72 %
20 Days --0.670
-8.90 %
Medium Term Return 3 Months 0.059-0.310
-3.50 %
6 Months 0.059-0.160
-1.44 %
1 Year 0.114+0.670
+12.67 %
Long Term Return 2 Years 0.221+0.670
+14.39 %
3 Years 0.321+2.040
+48.98 %
5 Years 0.493-0.870
-4.88 %
Annualised Return Annualised --
-1.00 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 5.730 - 8.150 Change From 1 Year Low +1.130 % Change From 1 Year Low (%) +19.72
Change From 1 Year High -1.290 % Change From 1 Year High (%) -15.83
2 Years Range 4.770 - 8.150 Change From 2 Years Low +2.090 % Change From 2 Years Low (%) +43.82
Change From 2 Years High -1.290 % Change From 2 Years High (%) -15.83
5 Years Range 4.110 - 8.920 Change From 5 Years Low +2.750 % Change From 5 Years Low (%) +66.91
Change From 5 Years High -2.060 % Change From 5 Years High (%) -23.09
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical devices. It operates through the following segments: Single Use Medical Device Products, Orthopedic Products, and Others. The Single Use Medical Device Products segment involves in the production and sale of single use consumables such as infusion sets, syringes, blood transfusion sets, and blood bags. The Orthopedic Products segment includes production and sale of orthopedic products such as platelet segregator, blood plasma catheter, and blood cell segregator. The Others segment consists of finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.

Historical Price Data

Date Open High Low Close Volume VWAP
16 Aug 2019 6.780 6.970 6.740 6.860 7,068,000 6.8621
15 Aug 2019 6.750 6.840 6.600 6.780 2,956,000 6.7648
14 Aug 2019 6.850 6.860 6.700 6.740 4,539,411 6.7678
13 Aug 2019 6.980 6.980 6.710 6.710 6,506,333 6.7553
12 Aug 2019 6.940 6.960 6.820 6.950 3,987,000 6.9245
09 Aug 2019 6.930 7.080 6.870 6.870 5,489,697 6.9801
08 Aug 2019 6.980 7.040 6.880 6.960 6,222,090 7.0395
07 Aug 2019 6.930 7.140 6.880 6.890 10,970,910 6.9430
06 Aug 2019 7.000 7.050 6.800 6.950 11,165,825 6.9192
05 Aug 2019 7.190 7.200 7.100 7.100 4,660,389 7.1283
02 Aug 2019 7.380 7.380 7.190 7.200 6,836,000 7.2294
01 Aug 2019 7.410 7.490 7.180 7.440 6,500,783 7.3944
31 Jul 2019 7.530 7.740 7.490 7.520 4,563,100 7.6327
30 Jul 2019 7.570 7.690 7.570 7.580 4,886,600 7.5917
29 Jul 2019 7.510 7.600 7.390 7.590 3,938,278 7.5495
26 Jul 2019 7.640 7.690 7.370 7.460 11,400,820 7.7705
25 Jul 2019 7.210 7.580 7.210 7.580 12,736,429 7.4583
24 Jul 2019 7.230 7.260 7.170 7.170 8,744,184 7.2775
23 Jul 2019 7.200 7.370 7.180 7.220 6,596,691 7.3456
22 Jul 2019 7.230 7.370 7.100 7.210 145,511,414 7.6074
19 Jul 2019 7.520 7.700 7.520 7.530 9,828,691 7.6007
18 Jul 2019 7.480 7.550 7.440 7.520 9,388,000 7.5175
Summary
Current 2 Weeks
(05 Aug 2019 to 16 Aug 2019)
7.190 7.200 6.600 6.860 63,565,655 -
Previous 2 Weeks
(22 Jul 2019 to 02 Aug 2019)
7.230 7.370 6.600 7.200 211,714,299 -
4 Weeks from
(21 Jun 2019 to 19 Jul 2019)
7.300 7.360 6.600 7.530 272,797,261 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.